Simonetti O, Armocida E, Rossi B, Samassa F, Gobbo Y, Luzzati R
Pathog Glob Health. 2025; 119(1-2):22-28.
PMID: 39894965
PMC: 11905301.
DOI: 10.1080/20477724.2025.2458977.
Gupta S, Thornley S, Morris A, Sundborn G, Grant C
Trop Med Int Health. 2024; 29(12):1006-1017.
PMID: 39575757
PMC: 11613430.
DOI: 10.1111/tmi.14058.
Chikezie F, Veriegh F, Armoo S, Boakye D, Taylor M, Osei-Atweneboana M
Parasit Vectors. 2024; 17(1):394.
PMID: 39289756
PMC: 11409746.
DOI: 10.1186/s13071-024-06333-2.
Fodjo J, Ekome S, Njamnshi J, Njamnshi W, Njamnshi K, Ngarka L
Int J Environ Res Public Health. 2024; 21(6).
PMID: 38928904
PMC: 11204025.
DOI: 10.3390/ijerph21060658.
Chunda V, Fombad F, Kien C, Ebai R, Esofi F, Ntuh A
Front Trop Dis. 2024; 5:1293632.
PMID: 38655273
PMC: 7615855.
DOI: 10.3389/fitd.2024.1293632.
Significant reduction of blackfly densities in persistent onchocerciasis area following pilot implementation of an environment friendly approach (Slash and Clear).
Domche A, Nana Djeunga H, Nwane P, Njitchouang G, Nono Fesuh B, Njiokou F
Sci Rep. 2024; 14(1):408.
PMID: 38172522
PMC: 10764779.
DOI: 10.1038/s41598-023-50747-4.
Onchocerciasis in the Ntui Health District of Cameroon: epidemiological, entomological and parasitological findings in relation to elimination prospects.
Fodjo J, Ngarka L, Njamnshi W, Enyong P, Zoung-Kanyi Bissek A, Njamnshi A
Parasit Vectors. 2022; 15(1):444.
PMID: 36443885
PMC: 9702945.
DOI: 10.1186/s13071-022-05585-0.
Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling study.
Borlase A, Le Rutte E, Castano S, Blok D, Toor J, Giardina F
Lancet Glob Health. 2022; 10(11):e1600-e1611.
PMID: 36240827
PMC: 9579354.
DOI: 10.1016/S2214-109X(22)00360-6.
Dermatology on the global stage: The role of dermatologists in international health advocacy and COVID-19 research.
Prasad S, Bassett I, Freeman E
Int J Womens Dermatol. 2021; 7(5):653-659.
PMID: 34722850
PMC: 8539819.
DOI: 10.1016/j.ijwd.2021.10.003.
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?.
Vinkeles Melchers N, Stolk W, Murdoch M, Pedrique B, Kloek M, Bakker R
PLoS Negl Trop Dis. 2021; 15(6):e0009489.
PMID: 34115752
PMC: 8221783.
DOI: 10.1371/journal.pntd.0009489.
Ivermectin Treatment Coverage Validation in Two Onchocerciasis Endemic Districts in Ethiopia: A Community-Based Cross-Sectional Study, 2019.
Churko C, Yihune M, Teshome A, Chisha Y, Getachew B, Sleshi M
J Multidiscip Healthc. 2021; 14:137-144.
PMID: 33500622
PMC: 7822083.
DOI: 10.2147/JMDH.S288239.
Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon.
Forrer A, Wanji S, Obie E, Nji T, Hamill L, Ozano K
BMJ Glob Health. 2021; 6(1).
PMID: 33431378
PMC: 7802695.
DOI: 10.1136/bmjgh-2020-003248.
A Rare Case of Cutaneous Onchocerciasis in North-East India, Review of Literature.
Pasha M, Patil C, Tanuja M, Mitra D
Indian Dermatol Online J. 2020; 11(4):600-603.
PMID: 32832451
PMC: 7413433.
DOI: 10.4103/idoj.IDOJ_555_19.
Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia.
Gebrezgabiher G, Mekonnen Z, Yewhalaw D, Hailu A
BMC Public Health. 2020; 20(1):1233.
PMID: 32787813
PMC: 7425055.
DOI: 10.1186/s12889-020-09344-7.
Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
Wanji S, Nji T, Hamill L, Dean L, Ozano K, Njouendou A
Parasit Vectors. 2019; 12(1):574.
PMID: 31801631
PMC: 6894124.
DOI: 10.1186/s13071-019-3826-8.
Neurological manifestations in Onchocerca volvulus infection: A review.
Hotterbeekx A, Namale Ssonko V, Oyet W, Lakwo T, Idro R
Brain Res Bull. 2018; 145:39-44.
PMID: 30458251
PMC: 6382410.
DOI: 10.1016/j.brainresbull.2018.08.024.
Onchodermatitis: Where Are We Now?.
Murdoch M
Trop Med Infect Dis. 2018; 3(3).
PMID: 30274490
PMC: 6160948.
DOI: 10.3390/tropicalmed3030094.
Insights Into Onchocerca volvulus Population Biology Through Multilocus Immunophenotyping.
Norice-Tra C, Ribeiro J, Bennuru S, Fay M, Tyagi R, Mitreva M
J Infect Dis. 2017; 216(6):736-743.
PMID: 28934436
PMC: 5853885.
DOI: 10.1093/infdis/jix394.
Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention.
Osue H
Ethiop J Health Sci. 2017; 27(2):129-138.
PMID: 28579708
PMC: 5440827.
DOI: 10.4314/ejhs.v27i2.5.
Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea Savanna, Northern Nigeria.
Murdoch M, Murdoch I, Evans J, Yahaya H, Njepuome N, Cousens S
PLoS Negl Trop Dis. 2017; 11(3):e0005489.
PMID: 28355223
PMC: 5386293.
DOI: 10.1371/journal.pntd.0005489.